Abstract | BACKGROUND: METHOD: Exosomes were extracted from the urine of 83 participants to determine the expression levels of miRNA-615-3p and miRNA-3147 in 20 healthy people, 21 patients with T2DM and 42 patients with DKD, as determined by RT-qPCR. The circulating expression level of TGF-β1 was detected by ELISA. Serum Cystatin C was measured by a latex-enhanced immunoturbidimetric method. The correlation analyses were performed for all clinical and laboratory parameters. RESULT: The expression level of urinary exosomal miRNA-615-3p in DKD patients was significantly higher than that in the control group and the T2DM group by RT-qPCR. The expression of miRNA-3147 showed an upward trend in the three groups of subjects, but it was not statistically significant. The urinary exosomal miRNA-615-3p was positively correlated with serum Cystatin C, plasma TGF-β1, creatinine, BUN, PCR and 24-h urine protein, and negatively correlated with eGFR and albumin. The diagnostic efficacy of urinary exosomal miRNA-615-3p combined with the ACR was higher than that of ACR alone. CONCLUSIONS: Urinary exosomal miRNA-615-3p may be used as a novel biomarker for evaluating the progression of DKD, and may be involved in the process of inflammation and fibrosis in DKD. The combined diagnosis of urinary exosomal miRNA-615-3p and ACR may be used as more stable and sensitive diagnostic criteria for DKD.
|
Authors | Jiaxin Wang, Yiying Tao, Fan Zhao, Tong Liu, Xiahong Shen, Ling Zhou |
Journal | Renal failure
(Ren Fail)
Vol. 45
Issue 1
Pg. 2121929
(Dec 2023)
ISSN: 1525-6049 [Electronic] England |
PMID | 36695327
(Publication Type: Journal Article)
|
Chemical References |
- MicroRNAs
- Cystatin C
- Transforming Growth Factor beta1
- Biomarkers
|
Topics |
- Humans
- MicroRNAs
(urine)
- Diabetic Nephropathies
- Cystatin C
- Transforming Growth Factor beta1
- Diabetes Mellitus, Type 2
- Biomarkers
- Inflammation
- Fibrosis
|